Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2526]

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging

Researchers have unlocked secrets about engineered protein receptor CAR

Researchers have unlocked secrets about engineered protein receptor CAR

Antihormone therapy linked with higher heart failure risk in prostate cancer patients

Antihormone therapy linked with higher heart failure risk in prostate cancer patients

Brain-derived compounds show surprising and beneficial results for cancer in lab studies

Brain-derived compounds show surprising and beneficial results for cancer in lab studies

Men with prostate cancer willing to accept lower survival odds to avoid side effects

Men with prostate cancer willing to accept lower survival odds to avoid side effects

European Commission approves enzalutamide for high-risk nmCRPC

European Commission approves enzalutamide for high-risk nmCRPC

ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma

ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma

ESMO 2018: Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

ESMO 2018: Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

DNA molecule may one day be used as 'vaccine' for prostate cancer

DNA molecule may one day be used as 'vaccine' for prostate cancer

More from ecancer